These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 11123429)

  • 1. Synergistic suppressive effect of double transfection of tumor necrosis factor-alpha and interleukin 12 genes on tumorigenicity of Meth-A cells.
    Fujiwara H; Yamauchi N; Sato Y; Sasaki K; Takahashi M; Okamoto T; Sato T; Iyama S; Koshita Y; Hirayama M; Yamagishi H; Niitsu Y
    Jpn J Cancer Res; 2000 Dec; 91(12):1296-302. PubMed ID: 11123429
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rapid generation of potent and tumor-specific cytotoxic T lymphocytes by interleukin 18 using dendritic cells and natural killer cells.
    Tanaka F; Hashimoto W; Okamura H; Robbins PD; Lotze MT; Tahara H
    Cancer Res; 2000 Sep; 60(17):4838-44. PubMed ID: 10987295
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cytokines alter target cell susceptibility to lysis: I. Evaluation of non-major histocompatibility complex-restricted effectors reveals differential effects on natural and lymphokine-activated killing.
    Wiebke EA; Custer MC; Rosenberg SA; Lotze MT
    J Biol Response Mod; 1990 Apr; 9(2):113-26. PubMed ID: 2111373
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dendritic cell-tumor coculturing vaccine can induce antitumor immunity through both NK and CTL interaction.
    Kim KD; Choi SC; Kim A; Choe YK; Choe IS; Lim JS
    Int Immunopharmacol; 2001 Nov; 1(12):2117-29. PubMed ID: 11710541
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Compromised anti-tumor responses in tumor necrosis factor-alpha knockout mice.
    Baxevanis CN; Voutsas IF; Tsitsilonis OE; Tsiatas ML; Gritzapis AD; Papamichail M
    Eur J Immunol; 2000 Jul; 30(7):1957-66. PubMed ID: 10940885
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Systemic administration of rIL-12 synergistically enhances the therapeutic effect of a TNF gene-transduced cancer vaccine.
    Taniguchi F; Yamagishi H; Fujiwara H; Ueda Y; Fuji N; Yoshimura T; Oka T
    Gene Ther; 1998 Dec; 5(12):1677-84. PubMed ID: 10023447
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Augmented systemic immunity in mice implanted with tumor necrosis factor-alpha gene-transduced Meth-A-cells.
    Fujii S; Liu Y; Neda H; Itoh Y; Koshita Y; Takahashi M; Watanabe N; Kohgo Y; Niitsu Y
    Jpn J Cancer Res; 1994 Mar; 85(3):315-24. PubMed ID: 8188531
    [TBL] [Abstract][Full Text] [Related]  

  • 8. IL-10 converts mouse lymphoma cells to a CTL-resistant, NK-sensitive phenotype with low but peptide-inducible MHC class I expression.
    Salazar-Onfray F; Petersson M; Franksson L; Matsuda M; Blankenstein T; Kärre K; Kiessling R
    J Immunol; 1995 Jun; 154(12):6291-8. PubMed ID: 7759867
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inoculation of human interleukin-17 gene-transfected Meth-A fibrosarcoma cells induces T cell-dependent tumor-specific immunity in mice.
    Hirahara N; Nio Y; Sasaki S; Minari Y; Takamura M; Iguchi C; Dong M; Yamasawa K; Tamura K
    Oncology; 2001; 61(1):79-89. PubMed ID: 11474253
    [TBL] [Abstract][Full Text] [Related]  

  • 10. B7-1 enhances natural killer cell-mediated cytotoxicity and inhibits tumor growth of a poorly immunogenic murine carcinoma.
    Yeh KY; Pulaski BA; Woods ML; McAdam AJ; Gaspari AA; Frelinger JG; Lord EM
    Cell Immunol; 1995 Oct; 165(2):217-24. PubMed ID: 7553886
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of immunization with tumor cells double transfected with interleukin-2 (IL-2) and interleukin-12 (IL-12) genes on artificial metastasis of colon26 cells in BALB/c mice.
    Takada T; Kato K; Yagita H; Hamada H; Okumura K
    Clin Exp Metastasis; 1999 Mar; 17(2):125-30. PubMed ID: 10411104
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Influence of gene-modified (IL-7, IL-4, and B7) tumor cell vaccines on tumor antigen presentation.
    Cayeux S; Richter G; Noffz G; Dörken B; Blankenstein T
    J Immunol; 1997 Mar; 158(6):2834-41. PubMed ID: 9058819
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Activation and regulation of macrophages induced by inoculation of cryodestroyed tumor cells].
    Tsujino M
    Osaka Daigaku Shigaku Zasshi; 1990 Jun; 35(1):180-205. PubMed ID: 2135404
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of B7-1 by Pam 212 squamous cell carcinoma enhances tumor cell interactions with dendritic epidermal cells but does not affect in vivo tumor growth.
    Yeh KY; Chen Z; Nasir A; Ohsuga Y; Takashima A; Lord EM; Gaspari AA
    J Invest Dermatol; 1997 Dec; 109(6):728-33. PubMed ID: 9406812
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dual effects of cytokines in regulation of MHC-unrestricted cell mediated cytotoxicity.
    Reiter Z
    Crit Rev Immunol; 1993; 13(1):1-34. PubMed ID: 8466640
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Involvement of MHC class I molecule and ICAM-1 in the enhancement of adhesion and cytotoxic susceptibility to immune effector cells of tumor cells transfected with the interleukin (IL)-2, IL-4 or IL-6 gene.
    Cao X; Chen G; He L; Zhang W; Yu Y; Wang J
    J Cancer Res Clin Oncol; 1997; 123(11-12):602-8. PubMed ID: 9620217
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Relation of natural killer cell line NK-92-mediated cytolysis (NK-92-lysis) with the surface markers of major histocompatibility complex class I antigens, adhesion molecules, and Fas of target cells.
    Komatsu F; Kajiwara M
    Oncol Res; 1998; 10(10):483-9. PubMed ID: 10338151
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tumour cell vaccines that secrete interleukin-2 (IL-2) and interferon gamma (IFN gamma) are recognised by T cells while resisting destruction by natural killer (NK) cells.
    Zier KS; Gansbacher B
    Eur J Cancer; 1996 Jul; 32A(8):1408-12. PubMed ID: 8869107
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Effects of hMIP-1beta gene modification on in vivo tumorigenicity and vaccine efficacy of tumor cells].
    Luo XL; Xie YA; Kuang ZP; Wu JN; Liang AM
    Zhonghua Zhong Liu Za Zhi; 2008 Feb; 30(2):97-102. PubMed ID: 18646689
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A novel beta 4, alpha 6 integrin-associated epithelial cell antigen involved in natural killer cell and antigen-specific cytotoxic T lymphocyte cytotoxicity.
    Phillips JH; McKinney L; Azuma M; Spits H; Lanier LL
    J Exp Med; 1991 Dec; 174(6):1571-81. PubMed ID: 1744585
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.